GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal influence of schizophrenia

the 23andMe Research Team, The Substance Use Disorders Working Group of the Psychiatric Genomics Consortium, International Cannabis Consortium

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal influence of schizophrenia'. Together they form a unique fingerprint.

Medicine & Life Sciences